Macau Casino Gambli...
Affymetrix Inc. (AFFX: NASDAQ)
$4.57 -0.17 | -3.59%
06/01/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 267.47M | 310.75M | 327.09M | 410.25M |
| Cost of Sales | 78.24M | 96.90M | 102.78M | 99.16M |
| Gross Operating Profit | 189.24M | 213.84M | 224.32M | 311.09M |
| Selling, General, and Administrative Expenses | 109.57M | 114.77M | 130.84M | 127.16M |
| Research & Development | 63.59M | 67.93M | 77.36M | 84.48M |
| Operating Income before D & A (EBITDA) | 16.08M | 31.13M | 16.12M | 99.45M |
| Depreciation & Amortization | 32.72M | 36.30M | 47.55M | 52.98M |
| Interest Income | 6.30M | 1.49M | 2.59M | 14.63M |
| Other Income - Net | -12.60M | 3.32M | 17.45M | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 450.00K | -239.10M |
| Total Income Before Interest Expenses (EBIT) | -22.94M | -357.00K | -13.12M | -227.91M |
| Interest Expense | 3.81M | 7.71M | 10.94M | 14.09M |
| Pre-Tax Income | -26.76M | -8.06M | -24.07M | -242.00M |
| Income Taxes | 1.40M | 2.17M | -158.00K | 65.92M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -28.16M | -10.23M | -23.91M | -307.92M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -28.16M | -10.23M | -23.91M | -307.92M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -28.16M | -10.23M | -23.91M | -307.92M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-28.16M | -10.23M | -22.18M | -18.91M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -28.16M | -10.23M | -23.91M | -307.92M |
| Basic EPS from Continuing Ops. | -0.40 | -0.15 | -0.35 | -4.49 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.40 | -0.15 | -0.35 | -4.49 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.40 | -0.15 | -0.35 | -4.49 |
| Basic Normalized Net Income/Share | -0.40 | -0.15 | -0.32 | -0.28 |
| EPS fr Continuing Ops. | -0.40 | -0.15 | -0.35 | -4.49 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.40 | -0.15 | -0.35 | -4.49 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.40 | -0.15 | -0.35 | -4.49 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.40 | -0.15 | -0.32 | -0.28 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with AFFX
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserPART 7 JPMorgan 28th Annual...
- UserStockpickrOne
- UserLast Day of the JPMorgan He...
- ContributorFast Money's First 100 Days...
- ContributorBarron's Cheap Losers For A...
Latest AFFX Headlines from TheStreet
- Affymetrix's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.03.12 | 10:05 pm
- Affymetrix's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.08.12 | 10:02 pm
- 5 Stocks Set to Soar on Bullish Earnings 02.07.12 | 06:02 am
- Affymetrix Stock Hits New 52-Week Low (AFFX) 12.19.11 | 03:12 pm
- Affymetrix Stock Hits New 52-Week Low (AFFX) 12.09.11 | 10:12 am
- Affymetrix's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.02.11 | 08:11 pm
- ServiceSource, Illumina: After-Hours Trading 10.06.11 | 06:10 pm
- Affymetrix Inc. Stock Downgraded (AFFX) 08.05.11 | 07:08 am
- Affymetrix's CEO Discusses Q2 2011 Results - Earnings Call Transcript 07.27.11 | 11:07 pm
- 5 More Earnings Stocks Set to Soar 07.27.11 | 11:07 am
Press Releases for AFFX
- Affymetrix And Leica Microsystems Announce Worldwide Collaboration On Automated, Single-Copy, RNA In Situ Hybridization (ISH) Tissue Assay For Research Use - Business Wire 05.31.12 | 07:05 am
- Affymetrix And ScreenCell Announce Worldwide Distribution Agreement For Circulating Tumor Cell (CTC) Technology - Business Wire 05.17.12 | 07:05 am
- Affymetrix To Webcast Annual Meeting Of Shareholders - Business Wire 05.11.12 | 09:05 am
- Affymetrix And EBioscience Amend Definitive Merger Agreement - Business Wire 05.03.12 | 10:05 pm
- Affymetrix Reports First Quarter 2012 Results - Business Wire 05.03.12 | 04:05 pm
- Affymetrix To Host Conference Call On May 3, 2012 To Announce First Quarter 2012 Operating Results - Business Wire 04.17.12 | 04:04 pm
- Affymetrix Announces A Global Distribution Agreement With Almac To Distribute Its Proprietary Xcel™ Array For Translational Research Applications - Business Wire 03.29.12 | 07:03 am
- Lineagen Applies Affymetrix' GeneChip® Technology To Next-Generation FirstStepDx® Service For Individuals With Developmental Delay And Autism Spectrum Disorders - PR Newswire 03.28.12 | 07:03 am
- Affymetrix Axiom(R) Exome Genotyping Arrays (Photo: Business Wire) - Business Wire 02.23.12 | 09:02 am
- China Clears Its First Microarray Platform For In Vitro Diagnostics To Accelerate Personalized Medicine - Business Wire 02.15.12 | 06:02 pm
Partner Headlines for AFFX
- Affymetrix Inks Distribution Pact - Analyst Blog - Zacks 05.21.12 | 07:05 pm
- Benzinga's Top Upgrades with Color for May 9, 2012 - Benzinga 05.09.12 | 09:05 am
- Kinetics Hedge Fund's Top Undervalued Picks - Seeking Alpha 03.23.12 | 05:03 pm
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 03.16.12 | 09:03 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 03.12.12 | 09:03 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 03.08.12 | 09:03 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 02.14.12 | 09:02 am
- Luminex Beats on Assay Boost - Analyst Blog - Zacks 02.07.12 | 09:02 am
- UPDATE: Deutsche Bank Upgrades Affymetrix to Buy - Benzinga 01.25.12 | 09:01 am
- Deutsche Bank Upgrades Affymetrix to Buy - Benzinga 01.25.12 | 09:01 am





